Rontalizumab

Rontalizumab Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 021-61312847; 18021002903
Email: 3008007409@qq.com
Products Intro: Product Name:Rontalizumab (anti-IFNA1)
CAS:948570-30-7
Purity:ExactAb?, Validated, Carrier Free, Low Endotoxin, Azide Free Package:100μg Remarks:K13701
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Rontalizumab
CAS:948570-30-7
Purity:95% Package:100ug;500ug;1mg
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Products Intro: Product Name:Rontalizumab
CAS:948570-30-7
Purity:95% Package:1mg;1g;100g
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Products Intro: Product Name:Rontalizumab
Purity:>95%;1mg/ml Package:200ug;500ug;1mg
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com
Products Intro: Product Name:Rontalizumab
CAS:948570-30-7
Purity:>95% Package:1mg/RMB 2480;5mg/RMB 5580;10mg/RMB 7780
Rontalizumab Basic information
Product Name:Rontalizumab
Synonyms:Rontalizumab;Research Grade Rontalizumab;Rontalizumab (anti-IFNA1)
CAS:948570-30-7
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Rontalizumab Structure
Rontalizumab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Rontalizumab Usage And Synthesis
UsesRontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
References[1] McBride JM, et al. Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study. Arthritis Rheum. 2012 Nov;64(11):3666-76. DOI:10.1002/art.34632
Rontalizumab Preparation Products And Raw materials
Tag:Rontalizumab(948570-30-7) Related Product Information
Immunoglobulin M,anti-(human CD147 (antigen)) (mouse monoclonal ABX-CBL m-chain), disulfide with mousemonoclonal ABX-CBL light chain, pentamer Sudubrilimab Demupitamab Budigalimab Ianalumab Research Grade Clivatuzumab (DHD14205) Suvratoxumab Lupartumab Mavezelimab Vepalimomab